Phase IIb, Randomised, Double-blinded, Placebo Controlled, Multicentre Trial of Infliximab with Transcriptomic Biomarker and Mechanism Evaluation – RAPID-1 - Research Portal | Lancaster University

Home > Research > Projects > Phase IIb, Randomised, Double-blinded, Placebo ...

View graph of relations

Phase IIb, Randomised, Double-blinded, Placebo Controlled, Multicentre Trial of Infliximab with Transcriptomic Biomarker and Mechanism Evaluation – RAPID-1

Project: Research

Status	Finished
Effective start/end date	1/01/18 → 30/04/23

Funding

NIHR: £9,280.00

Jaki, Thomas (Principal Investigator)